Labiotech.eu

In Depth 28 Feb 2022

Biorobotics Teaches Machines to Sense and Respond to the World

Integrating biology and robotics would allow robots to feel, smell, or hear in order to react to changing environments, opening a wide range of applications. Our senses allow us to interact with our surroundings. They are also the basis for learning. In the quest to make machines more efficient, researchers are looking at one of […]

February 28, 2022 - 7 minutesmins - By Carlos de Rojas

Industrial plant sustainability bioeconomy

News and Trends 23 Feb 2022

EU Bioeconomy Fund Bags €300M to Scale up Sustainability Companies

The European Circular Bioeconomy Fund has smashed its funding target by raising €300M. The aim is to help sustainability-focused biotechs scale up and usher in a ‘bio-revolution’ in Europe. As European economies grapple with the aftershocks of the Covid-19 pandemic, policymakers have pledged to prioritize sustainability in plans such as the European Green Deal. However, […]

February 23, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 22 Feb 2022

Fast Stroke Treatments in the Works with TargED’s €39M Series A

Patients with sudden strokes and blood clotting conditions need faster and safer treatments. The Dutch company TargED Biopharmaceuticals has raised a €39M Series A round to fund the development of a fast-acting protein drug that could bridge this gap. Time is of the essence when treating acute ischemic stroke, a condition caused by a blood […]

February 22, 2022 - 5 minutesmins - By Jonathan Smith

Belgium biotech vc fund newton biocapital japan

News and Trends 18 Feb 2022

Belgian VC Fund Leads Investment Wave in Japanese Biotech

As US and European investor interest in Japanese biopharma startups spikes, the Belgian venture capital firm Newton Biocapital has launched a €150M fund to harness synergy between European and Japanese life sciences. Japan boasts a world-class technology industry in addition to a thriving life sciences scene. The nation hosts large companies including Takeda, Eisai, and […]

February 18, 2022 - 4 minutesmins - By Jonathan Smith

Best in Biotech 16 Feb 2022

Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem

These are the top biotech companies based in Stevenage, an English town that has become a life sciences hub that competes with the likes of London, Oxford, and Cambridge. The UK’s life sciences scene is mostly centered around the golden triangle of London, Oxford, and Cambridge. Situated right in the middle of this triangle, the […]

February 16, 2022 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 16 Feb 2022

Startup Bags €50M Series A to Smash Gene Therapy Vector Limits

After closing Spain’s largest biopharma Series A round, the company SpliceBio has set its foundations in the gene therapy field and joins the push to deliver bigger therapeutic genes into patients. SpliceBio was founded in 2012 to tinker with a type of protein called inteins, which can stick peptides together to form new proteins. The […]

February 16, 2022 - 5 minutesmins - By Jonathan Smith

News and Trends 15 Feb 2022

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to healthcare systems worldwide. Numerous treatments and vaccines are hitting the late-stage pipeline, which could greatly expand the anti-Covid-19 arsenal. Two years ago, the Covid-19 pandemic swept the world and left economic disruption, healthcare crises, and widespread lockdowns in its wake. […]

February 15, 2022 - 7 minutesmins - By Jonathan Smith

News and Trends 10 Feb 2022

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

An international academic team has made strides in carrying out genome sequencing faster and more cheaply in low- and middle- income nations. This could improve the control of potentially lethal salmonella infections and propel research into vaccines. As the price of DNA sequencing continues to fall, genomics and bioinformatics firms are drawing ever more attention […]

February 10, 2022 - 6 minutesmins - By Jonathan Smith

News and Trends 8 Feb 2022

Reforms of EU Clinical Trial Regulations Bring Cautious Optimism

The EU’s clinical trial regulations received a major overhaul at the end of January 2022 to make trials easier to run across EU member states. It may bring some short-term chaos, industry insiders say, but down the road it is likely to pay off. At the start of February, the EU’s new Clinical Trials Regulation […]

February 8, 2022 - 5 minutesmins - By Victor Kotsev

January Financial Top European Investments

News and Trends 3 Feb 2022

The Top European Biotech Investments in January 2022

Viral infection treatments, cell therapy, and artificial intelligence led biotech investments in January 2022 as the European sector took a collective breather from December’s funding frenzy. European biotech investments started 2022 at a modest level compared to the huge cash flow seen in November and December 2021. While December 2021 saw almost €1.6B money raised, […]

February 3, 2022 - 3 minutesmins - By Jonathan Smith

ethris mrna therapy respiratory infection

News and Trends 1 Feb 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Thanks to Covid-19 vaccines, messenger RNA (mRNA) technology has reached the mainstream. With a €23.4M Series B round, the German firm Ethris is riding the mRNA buzz by developing inhalable mRNA therapies for respiratory diseases. As Covid-19 mRNA vaccines entered the market for the first time in 2020, the wide potential of mRNA technology became […]

February 1, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 1 Feb 2022

Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A

The Viennese biotech startup Ribbon Biolabs has raised an €18M Series A round to reduce the costs of synthesizing long DNA molecules, which could accelerate research into synthetic biology and the storage of data as DNA. Supported by lead investor Hadean Ventures, Ribbon Biolabs’ fundraising round is part and parcel of a continuing investor interest […]

February 1, 2022 - 3 minutesmins - By Dan Samorodnitsky

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Biorobotics Teaches Machines to Sense and Respond to the World

EU Bioeconomy Fund Bags €300M to Scale up Sustainability Companies

Fast Stroke Treatments in the Works with TargED’s €39M Series A

Belgian VC Fund Leads Investment Wave in Japanese Biotech

Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem

Startup Bags €50M Series A to Smash Gene Therapy Vector Limits

Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials

Global Team-up Cuts Genomics Costs to Fight Salmonella Infections

Reforms of EU Clinical Trial Regulations Bring Cautious Optimism

The Top European Biotech Investments in January 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Ribbon Biolabs Pushes DNA Synthesis Length Limits with €18M Series A

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!